Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

NDA filed for Antizol

Dec. 13, 1996

New use claimed for olanzapine

Nov. 26, 1996

LecTec cleared to proceed with clinical testing of smoking cessation product

Nov. 22, 1996

Cocaine vaccine nearing clinic

Nov. 8, 1996

New therapeutic for smoking cessation to enter pivotal trials

Oct. 25, 1996

Nicotine inhaler for smoking cessation: Clinical trial results

Oct. 25, 1996

Cangene acquires iron chelator from Apotex

Oct. 18, 1996

Japanese scientists discover potential agent for siderosis

Oct. 11, 1996

Cocaine vaccine proven effective in animal model

Oct. 11, 1996

First launch for inhaled smoking cessation product

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...